Powered by Axial Data

Top Pharmaceuticals Private Equity Funds

Explore 201 Pharmaceuticals Private Equity Funds that source acquisition and investment opportunities on Axial’s M&A platform.

Axial Insights

Pharmaceuticals Private Equity Funds

201

Active Firms

14,250

TTM Deal Inquiries

$3M-$19M

Core Revenue Range

$800K-$4M

Core EBITDA Range


Florida 14%
California 11%
Texas 10%
New York 7%
New Jersey 4%

Focus: Control Investments | Capital Source: Committed Capital | Operating Approach: Scale & Exit

Showing 201-201 of 201 Private Equity Funds

Sorted by recent activity

FAQs & about us: https://www.circahealth.com/faqsTeam & investors: https://www.circahealth.com/team-linkGeneral description: We’re a [A] private equity fund that is [B] focused on acquiring and growing [C] a healthcare business [D] that is run by an owner-operator. [A] Private equity fund: our investors are a team. They have committed their capital (i.e. private equity) and their time to support our approach. They have been carefully chosen for: (1) their ethos on investing in small and medium sized businesses and taking a long term, growth-oriented position, (2) their experiences in…

Recent Transactions

This member has no reported closed transactions.

Stop Browsing. Start Transacting.

Join 20,000+ members who source deals, connect with counterparties, and close transactions on Axial.

Frequently Asked Questions

How are Private Equity Funds in this directory ordered?

Firms in the Pharmaceuticals Private Equity Funds directory are ordered based on recent deal activity on Axial. The default order reflects observed market signals rather than a subjective ranking of firm quality.

What information is included in each Private Equity Fund profile?

Each profile provides information about the firm’s areas of focus, transaction criteria, and relevant activity on Axial’s M&A platform. Together, these details provide a clearer view of where a firm is active and the types of companies and opportunities most relevant for it.

What company sizes are most common for Pharmaceuticals Private Equity Funds?

Based on activity on Axial’s M&A platform, the core revenue range for Pharmaceuticals Private Equity Funds is $3M-$19M, with a core EBITDA range of $800K-$4M. Company size can be an important indicator of fit, as firms often concentrate their experience, resources, and transaction activity within particular segments of the market.

How important is Life Sciences experience when evaluating Private Equity Funds?

Relevant Life Sciences experience can be an important consideration when evaluating a firm. Familiarity with the sector can provide a stronger understanding of its business models, market dynamics, valuation considerations, and transaction environment. The 201 firms included in this directory provide a starting point for identifying firms with relevant experience and activity in Life Sciences.

Do all Private Equity Funds in this directory focus exclusively on Life Sciences?

Not necessarily. Many firms are active across multiple industries, so inclusion in the Pharmaceuticals Private Equity Funds directory reflects relevant experience or activity in Life Sciences, rather than an exclusive sector focus. Individual profiles provide additional context on each firm’s areas of focus and activity within the sector.

How do I compare Private Equity Funds with experience in Life Sciences?

When comparing Private Equity Funds with experience in Life Sciences, consider factors such as size range, geographic reach, and recent transaction activity. These characteristics vary across the 201 firms included in the directory and can help identify firms that align with your needs.

How do I connect with Pharmaceuticals Private Equity Funds?

Axial can help you identify and connect with firms based on your objectives and what you are looking to accomplish. The process varies depending on your role and transaction needs. If you are interested in connecting with firms in the Pharmaceuticals Private Equity Funds directory, you can request information here.


Want to Keep Exploring?

Enter your details to access all firm profiles.

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

Explore Axial
Template